Topical photodynamic therapy

Archive of Oncology

Volumn 14, Issue 1-2, 2006, Pages 39-44

  Poljački, Mirjana ^a   Jovanović, Marina ^a   Matović, Ljubinka ^a   Lugonja, Branislava ^a   Gajić, Branislava ^a   Roš, Tatjana ^a  

^a Novi Sad University   (Serbia)

Author keywords

Administration, Topical; Aminolevulinic Acid; Carcinoma; Carcinoma, Basal Cell; Keratosis; Photochemotherapy; Squamous Cell

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CHLORINE; DOXORUBICIN; EMLA; FLUOROURACIL; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PORPHYRIN;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; BURN; CANCER RISK; CANCER SURGERY; CARCINOGENICITY; CLINICAL PROTOCOL; CLINICAL TRIAL; CRYOTHERAPY; EDEMA; ERYTHEMA; HUMAN; HYPERBARIC OXYGEN; HYPERPIGMENTATION; HYPOPIGMENTATION; MULTIMODALITY CANCER THERAPY; NONHUMAN; PAIN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRURITUS; REVIEW; SKIN CANCER; SKIN ULCER; SQUAMOUS CELL CARCINOMA; TISSUE INJURY; TREATMENT OUTCOME; TREATMENT RESPONSE; WOUND HEALING;

EID: 33748423994     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0602039P     Document Type: Review

References (70)

1. Von Tappeiner H, Jesionek A. Therapeutishe Versuche mit fluorescierenden Stoffen. Munch Med Wochenschr 1903;47:2042-4.
2. Policard A. Etude sur les aspects offers par des tumeurs experimentales examinees a la lumiere de Wood. CR Soc Biol 1924;91:1423-4.
3. Kennedy X, Potter RH, Pross DC. Photodynamic therapy with endogenous protoporfirin IX: basis principles and present clinical. J Photochem Photobiol B 1990;14:275-92.
4. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. Primary clinical response and long term follow-up of solar keratoses treated with topically applied 5-aminolaevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B Biol 1997;41:145-51.
5. Kurwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow RJ. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999;41:414-8.
6. Hurlimann AF. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolaevulinic acid in a nanocoloid lotion. Dermatology 1998;197:248-54.
7. Roberts DJH, Cainduff F. Photodynamic therapy of primary skin cancer a review. Br J Plast Surg 1995;48:360-70.
8. Stender IM, Look-Anderson J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999;24:154-9.
9. Stender IM, Wulf HC. Photodynamic therapy of recalcitrant warts with 5-aminolaevulinic acid: a retrospective analysis. Acta Derm Venereol (Stockh) 1999;79:400-1.
10. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant warts: randomised duble-blind trial. Lancet 2000;355:963-6.
11. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115:183-9.
12. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolaevunic acid. Arch Dermatol 2000;136:1093-5.
13. Boehncke W-H, Konig K, Kaufmann R, Scheffold W, Prümmer O, Sterry W. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 1994;286:300-3.
14. Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporfirin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996;107:76-81.
15. Robinson DJ, Collins P, Stringer MR, Vernon DI, Stables GI, Brown SB, et al. Improved response of plaque psoriasis after multiple treatment wit topical 5-aminolevulinic acid photodynamic therapy. Acta Derm Venereol (Stoch) 1999;79:451-5.
16. Orenstein A, Haik J, Tamir J, Winkler E, Trau H, Malik Z, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg 2000;26:765-70.
17. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002;146:552-67.
18. Ash DV, Brown SB. New drugs and future developments in photodynamic therapy. Eur J Cancer 1993;29A:1781-3.
19. Moan J. Properties for optimal PDT sensitizers. J Photochem Photobiol 1990;5:521-4.
20. Bohmer RM, Morstyn G. Uptake of hematoporphyrin derivate by normal and malignant cells: effect of serum, pH, temperature, and cell siye. Cancer Res 1985;45:5328-34.
21. Peng Q, Warloe T, Berg C, Moan J, Kongshaug M, Giercksky KE, et al. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997;65:235-51.
22. Brrathen L, Paredes B, Frölich K, Wijnen I, Warloe T, Fritsch C, et al. A dose-finding study of photodynamic therapy (PDT) with Metvix TM in actinic keratoses (AK). J Eur Dermatol Venereol 2000;14 Suppl. 1:38.
23. Basset-Seguin N, Bachmann I, Pavel S, Saksela O, Johnsson M, Ros A-M, et al. A dose-finding study of photodynamic therapy (PDT) with Metvix TM in patients with basal cell carcinoma (BCC). J Eur Dermatol Venereol 2000;14 Suppl. 1:39.
24. Horn M, Larkö O, Wulf HC. Photodynamic therapy (PDT) with Metvix cream 160mg/g in patients with basal cell carcinoma (BCC) unsuitable to conventional therapy. Presented at the Society for Investigative Dermatology, Washington DC; 2001.
25. Szeimies R-M, Radakovic S, Calzavara-Pinton PG, Sidoroff A, Hempel M, Ulrich J, et al. A prospective, randomized study comparing photodynamic therapy with Metvix, to cryotherapy in actinic keratoses. J Eur Acad Dermatol Venereol 2000;14 Suppl. 1:235.
26. Salim A, Morton CA. Comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2000;114 Suppl. 57:114.
27. Rhodes LE, Tsoukas MM, Anderson RR, Kollias N. Iontophoretic delevery of ALA provides a quantitative model for ALA pharmacokinetics and Pp IX phototoxyciti in human skin. J Invest Dermatol 1997;108:87-91.
28. Warloe T, Peng Q, Heyerdahl J, Moan J, Steen B, Giercksky KE. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. Proc SPIE 1995;2371:226-35.
29. Warloe T, Heyerdahl H, Peng Q, Giercksky K-E. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and skin penetration enhancer for basal cell carcinoma. Proc SPIE 1994;2371:226-35.
30. Orenstein A, Kostenich G, Roitman L, Tsur H, Ehrenberg B, Malik Z. Photodynamic therapy of malignant lesions of the skin mediated by topical application of 5-aminolaevulinic acid in combination with DMSO and EDTA. Lasers Life Sci 1996;7:1-9.
31. Santoro O, Banieramonte G, Melloni E, Marchesini R, Zunino F, Lepera P, et al. Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas. Cancer Res 1990;50:4501-3.
32. Pottier RH, Chow YFA, LaPlante JP, Truscott TG, Kennedy JC, Beiner LA. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 1996;44:679-87.
33. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-57.
34. Langmack K, Mehta R, Twyman P, Norris P. Topical photodynamic therapy at low fluency rates theory and practice. J Photochem Photobiol B Biol 2001;60:37-43.
35. Wolf P, Rieger E, Kerl H. An alternative treatment modalyty for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas? J Am Acad Dermatol 1993;28:17-21.
36. Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolaevulinic acid. Arch Dermatol 1997;133:727-32.
37. Stefanidou M, Tosca A, Themelis G, Vazgiouraki E, Balas C. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulonic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimalisation of the photodynamic therapy. Eur J Dermatol 2000;10:351-6.
38. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J. Green fight is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 1997;13:181-5.
39. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical 5-aminolaevulinic acid as an appropriate approach to routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B Biol 1995;29:53-7.
40. Svanberg K, Anderson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical 5-aminolaevulinic acid sensitisation and laser irradiation. Br J Dermatol 1994;130:743-51.
41. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumors using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 1995;133:282-8.
42. Morton CA, Whitehurst C, Moore JV, Mackie RM. Comparison of red and green light in the treatment of Bowen's disease by Photodynamic therapy. Br J Dermatol 2000;143:767-72.
43. Dijkstra AT, Majoie IML, van Dogen JWF, van Weelden H, van Vloten WA. Photodynamic therapy with violet light and topical δ-aminolaevulinic acid in the treatment of actinic keratoses, Bowen's disease and basal cell carcinoma. J Eur Dermatol Venereol 2001;15(6):550-5.
44. Morton CA, Whitehurst C, McColl JH, Moore JV, Mackie RM. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol 2001;137:319-24.
45. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996;135:766-71.
46. Stables GI, Stringer MR, Robinson DJ, Ash DJ. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatolo 1997;136:957-60.
47. Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999;140:514-7.
48. Martin A, Tope WD, Gerevelink JM, Starr JC, Fewkes JL, Flotte TJ, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 1995;287:665-74.
49. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, et al. 5-ALA based photodynamic therapy. Cancer 1997;79:2282-308.
50. Lui H, Salasche S, Kollias N, Wimberly J, Flotte T, Mclean D, et al. Photodynamic therapy of non-melanoma skin cancer with topical 5-aminolaevulinic acid: a clinical and histologic study. Arch Dermatol 1995;131:737-8.
51. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000;142:338-9.
52. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for non-melanoma skin cancers. Current review and update. Mol Immunol 2003;39:1133-6.
53. Wang I, Bendsoe N, Klinteberg CAF, Enejder AMK, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas? Results of a phase III clinical trial. Br J Dermatol 2001;144:832-40.
54. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P. Long-term clinical follow-up and histological changes of superficial non-melanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998;134:821-6.
55. Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology - an update. Photodermatol Photoimunol Photomed 2005;21:142-9
56. Fritsh C, Goery G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998;134:207-14.
57. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002;146:178-88.
58. Grossman M, Wimberly J, Dwyer P, Flotte T, Anderson RR. PDT for hirsutism. Lasers Surg Med 1995;Suppl S7:44.
59. Bissonette R, Shapiro J, Zeng H, Mclean DI, Lui H. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce regrowth in patients with extensive alopecia. Br J Dermatol 2000;143:1032-5.
60. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, Szeimies RM, Zwingers T, Höningsmann H, et al. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observe-blinded study. Br J Dermatol 2005;152:279-83.
61. Fuchs J, Weber S, Kaufmann R. Genotoxic potential of porphiryn type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy. Free Rad Biol Med 2000;28:537-48.
62. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997;66:493-6.
63. Varma S, Holt PJA, Anstey AV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol 2000;142:514-7.
64. Wolf P, Fink-Ruches R, Reimann-Weber A, Kerl H. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology 1997;194:53-4.
65. Van Hillegersberg R, Kort WJ, Wilson JHP. Current status of photodynamic therapy in oncology. Drugs 1994;48:510-27.
66. Nahabedian MY, Cohen RA, Contino MF, Terem TM, Wright WH, Berns MW, et al. Combination cytotoxic chemotherapy with siplastin or doxorobucin and photodynamic therapy in murine tumors. J Natl Cancer Inst 1988;80:739-43.
67. Wolf P. Photodynamische Therapie (PDT). Hautarzt 1997;48:137-48.
68. Fisher AMR, Murphee AL, Gomer CJ. Clinical and precinical photodymanic therapy. Laser Surg Med 1995;17:2-31.
69. Henderson BW. Photodynamic therapy: coming of age. Photodermatology 1989;6:200-11.
70. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000;42:389-413.